RFX6 and neoplasm: Moreover, metabolite levels showed that silencing PGAM1 markedly suppressed the RFX6‐induced glycolysis in vivo, presenting as attenuated lactate and 2‐PG production in the subcutaneous tumours from the stable PGAM1‐KD groups (Figure 6K).